Solace Pharmaceuticals Inc. Lands $6,749,000 New Funding Round

  • Feed Type
  • Date
    3/31/2008
  • Company Name
    Solace Pharmaceuticals Inc.
  • Mailing Address
    222 Berkeley Street Boston, MA 02116
  • Company Description
    Solace was co-founded in March 2006 by PureTech Ventures and a preeminent team of scientific, clinical, regulatory and drug development experts who are collaborating to translate groundbreaking scientific discoveries in pain biology into innovative, effective therapeutic strategies for addressing chronic pain. Solace Pharmaceuticals is developing innovative therapies for treating chronic pain based on recent groundbreaking scientific discoveries. The company has promising programs at varying stages of preclinical and clinical development in its pipeline.
  • Website
    http://www.solacepharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,749,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    InterWest Partners
  • Venture Investor
    Polaris Venture Partners

Trending on Xconomy